Search Results - "Simetic, Luka"

Successful clinical approach to the metastatic uterine leiomyosarcoma to the epicardium-a case report by Krzelj, Kristina, Lekic, Ante, Luksic, Vlatka Reskovic, Milicic, Davor, Ilic, Ivana, Simetic, Luka, Dzepina, Zrinka Starcevic, Gasparovic, Hrvoje, Biocina, Bojan, Safradin, Ivica

“…Uterine leiomyosarcoma is a rare and aggressive tumour with a poor prognosis. Its metastases to the heart are even rarer, especially to the epicardium. The…”
Get full text

Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma by Batinac, Tanja, Hlača, Nika, Simetić, Luka, Valković, Frane, Peternel, Sandra, Prpić-Massari, Larisa

“…Abstract is missing (Short communication)…”
Get full text

Could fecal microbial transplantation offer a new potential in the treatment of metastatic pancreatic ductal adenocarcinoma? by Golčić, Marin, Simetić, Luka, Majnarić, Tea, Golčić, Goran, Herceg, Davorin

“…Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers due to its aggressiveness and resistance to anti-cancer medications. Recent data…”
Get full text

Analysis of clinical factors associated with survival in patients with soft-tissue sarcoma receiving trabectedin by Simetić, Luka, Blažičević, Krešimir, Ladenhauser, Tatjana, Golčić, Marin, Majnarić, Tea, Herceg, Davorin

“…Soft-tissue sarcomas (STSs) are a heterogeneous group of rare malignancies. Treatment for advanced STS usually starts with anthracycline-based therapies, with…”
Get full text

Relative Change in S100 as a Biomarker of Survival in Patients With Metastatic Melanoma Treated With Pembrolizumab by Simetić, Luka, Blažičević, Krešimir, Međugorac, Kata, Golčić, Marin, Herceg, Davorin

“…There is a lack of quality biomarkers of survival for patients with metastatic melanoma treated with immunotherapy. Although the baseline level of S100 has…”
Get full text

Severe Demyelinating Polyneuropathy and Cranial Neuropathy During Avelumab Treatment of Metastatic Merkel Cell Carcinoma by Bilić, Hrvoje, Sitaš, Barbara, Hančević, Mirea, Habek, Mario, Simetić, Luka, Bilić, Ervina

“…INTRODUCTIONAvelumab is a programmed death ligand 1-blocking monoclonal antibody used for the treatment of Merkel cell carcinoma (MCC), urothelial carcinoma,…”
Get full text

Impact of anthracycline-based chemotherapy on RB1 gene methylation in peripheral blood leukocytes and biomarkers of oxidative stress and inflammation in sarcoma patients by Pokupec Bilić, Anita, Bilić, Ivan, Radić Brkanac, Sandra, Simetić, Luka, Blažičević, Krešimir, Herceg, Davorin, Mikloš, Morana, Tonković Đurišević, Ivana, Domijan, Ana-Marija

“…Purpose We investigated the impact of anthracycline-based chemotherapy on methylation status of RB1 gene in peripheral blood leukocytes together with…”
Get full text

Adjuvant treatments in melanoma by Simetić, Luka, Blažević, Krešimir, Herceg, Davorin

“…For decades, interferon-alpha (IFN-α) has been the only option in the adjuvant treatment of high-risk melanoma. Despite numerous clinical trials and…”
Get full text

Analysis of the Gut Microbiome and Dietary Habits in Metastatic Melanoma Patients with a Complete and Sustained Response to Immunotherapy by Golčić, Marin, Simetić, Luka, Herceg, Davorin, Blažičević, Krešimir, Kenđel Jovanović, Gordana, Dražić, Ivan, Belančić, Andrej, Skočibušić, Nataša, Palčevski, Dora, Rubinić, Igor, Vlahović-Palčevski, Vera, Majnarić, Tea, Dobrila-Dintinjana, Renata, Pleština, Stjepko

“…Immunotherapy has improved the prognosis of metastatic melanoma patients, although most patients do not achieve a complete response. While specific gut…”
Get full text

Fatal outcome of posterior "reversible" encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluoropyrimidine chemotherapy regimen by Dedić Plavetić, Natalija, Rakušić, Zoran, Ozretić, David, Simetić, Luka, Krpan, Ana Mišir, Bišof, Vesna

“…Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, and visual…”
Get full text

Efficacy comparison of pazopanib and trabectedin vs standard chemotherapy in second line treatment of patients with metastatic soft tissue sarcomas: Experience from countries with limited resources by Pasic, Anes, Simetic, Luka, Herceg, Davorin, Ceric, Timur, Kapisazovic, Elma, Beslija, Semir

“…Abstract only…”
Get full text

Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe: An initiative of the Central European Cooperative Oncology Group (CECOG) by Thallinger, Christiane, Berzinec, Peter, Bicakcic, Emina, Dan, Adelina, Fabian, Gabriella, Gales, Laurentia Nicoletta, Kuhar, Cvetka Grasic, Janzic, Urska, Kahan, Zsusanna, Mencinger, Marina, Penthedourakis, George, Sgouros, Joseph, Simetic, Luka, Sirbu, Daniela, Vosmik, Milan, Wrona, Anna, Zielinski, Christoph

“…Summary Purpose To establish a transborder virtual tumor board (VTB) fostering state-of-the-art management of cancer patients by exchanging knowledge and…”
Get full text

Analysis of clinical factors associated with survival in patients with soft-tissue sarcoma receiving trabectedin by Simetić, Luka, Blažičević, Krešimir, Ladenhauser, Tatjana, Golčić, Marin, Majnarić, Tea, Herceg, Davorin

Get full text

Severe Demyelinating Polyneuropathy and Cranial Neuropathy During Avelumab Treatment of Metastatic Merkel Cell Carcinoma by Bilić, Hrvoje, Sitaš, Barbara, Hančević, Mirea, Habek, Mario, Simetić, Luka, Bilić, Ervina

Get full text

Personalized Dietary Intervention Based on Mediterranean Diet as a Complementary Strategy to Modify Gut Microbiome, Quality of Life and Outcomes in Patients with Metastatic Melanoma Treated with Immunotherapy: A Study Protocol by Nataša Skočibušić, Andrej Belančić, Gordana Kenđel Jovanović, Marin Golčić, Davorin Herceg, Luka Simetić, Krešimir Blažičević

“…Not all cancer patients respond to immunotherapy, and the variation in response may be attributed to an individual’s microbiome, which is profoundly influenced…”
Get full text

SMJERNICE ZA PROVOĐENJE DIJAGNOSTIČKIH PRETRAGA PRIJE POČETKA LIJEČENJA ONKOLOŠKOG BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a II. dio: rak dojke, ginekološki tumori (rak jajnika, rak tijela maternice, rak vrata maternice), rak pluća, maligni melanom, sarkomi, tumori središnjega živčanog sustava, rak glave i vrata by Dedić Plavetić, Natalija, Silovski, Tajana, Tečić Vuger, Ana, Pavlović, Mirjana, Vazdar, Ljubica, Herceg, Davorin, Simetić, Luka, Grubišić Čabo, Filip, Jakopović, Marko, Horvatić-Herceg, Gordana, Pedišić, Ivo, Herceg, Tonko, Šeparović, Robert, Vrbanec, Damir

“…Rak je drugi najvažniji uzrok smrti u našoj zemlji, odmah nakon bolesti srca i krvnih žila. S pretpostavkom porasta incidencije i smrtnosti od raka u idućim…”
Get full text